Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026 at 11:00 a.m. Eastern Time. The presentation will be available via a live webcast and a replay will be accessible in the company's Event Archive for two weeks.
Positive
- None.
Negative
- None.
News Market Reaction – INSP
In the Apr 29 session, INSP declined 3.08%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 06 | Earnings date notice | Neutral | -1.6% | Announced timing and webcast details for Q1 2026 results release. |
| Mar 03 | Investor conference | Neutral | +1.5% | Management presentation at KeyBanc Healthcare Forum with webcast access. |
| Feb 11 | Earnings results | Positive | -12.6% | Reported strong 4Q25 and FY25 results and revised 2026 revenue guidance. |
| Jan 12 | Prelim earnings | Positive | -1.5% | Released preliminary Q4 and FY25 revenue and initial 2026 guidance. |
| Jan 07 | Earnings date notice | Neutral | +1.9% | Set date and webcast details for 4Q25 and FY25 results release. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows negative price reactions following positive earnings-related updates, while routine scheduling and conference announcements have seen more mixed to slightly positive moves.
Over the last six months, Inspire Medical Systems reported strong 4Q25 and FY25 results with revenue of $269.1M for 4Q and $912.0M for 2025, plus updated 2026 guidance. Preliminary revenue and guidance in early January also preceded the full results. The stock showed negative moves after these fundamentally positive updates, while neutral items such as earnings-date notices and conference presentations around February 11, 2026 and March 17, 2026 produced smaller, mixed reactions. Today’s BofA conference notice fits that non-fundamental, visibility-focused pattern.
Key Terms
obstructive sleep apnea medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, April 29, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026.
Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
